Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05842863 · ClinicalTrials.gov registry record · NA

Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide

A NA study of Suicide and Self-harm, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
44
Enrollment target
1
Study location

NCT05842863: Recruiting NA study of Suicide and Self-harm, sponsored by Stanford University.

NCT05842863 is a NA study of Suicide and Self-harm that is actively recruiting participants, run by Stanford University. The registered enrollment target is 44 participants, below the 177-participant average among 11 other Suicide and Self-harm trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05842863, a NA study of Suicide and Self-harm, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
44 participants
Enrollment target
1
Study location

Study Summary

The proposed research addresses the urgent need to reduce suicide rates among teens. This will be the first study that the investigators know of that will examine the feasibility and preliminary effectiveness of augmenting a suicide-focused treatment (Dialectical Behavior Therapy, \[DBT\]) with an evidence-based treatment protocol for insomnia (a digital version of Cognitive Behavioral Therapy for Insomnia \[CBT-I\]). The goal of this clinical trial is to learn providing insomnia treatment in conjunction with suicide-focused treatment leads to greater reductions in suicidality and self-harm than suicide-focused treatment alone. Participants will be randomly assigned to receive 6 months of DBT plus CBT-I or to DBT alone and will complete research assessments measuring suicidal ideation, self-harm behavior and insomnia symptoms every four weeks over the course of the study, as well as one post-treatment follow-up assessment. Participants will also wear a device on their wrist (like a Fitbit or wristwatch) for 10 days following each assessment to collect data about their sleep.

Primary Outcome

The SIQ-JR (Reynolds 1987) is a 15-item self-report questionnaire that assesses suicidal thoughts on a 7-point scale (I never had this thought to almost every day). Scores range from 0 to 90, with a published clinical cut-off score of 31.

Conditions Studied

Interventions

  • BEHAVIORAL Dialectical Behavior Therapy
  • BEHAVIORAL Cognitive Behavioral Therapy for Insomnia

Study Locations (1)

California

  • Michele Berk - Stanford

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2024-08-14
Est. Completion 2026-06-30
Phase NA
Stanford University

1,744 total trials

What NCT05842863 shows while recruiting

NCT05842863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 177-participant average among 11 other Suicide and Self-harm trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Suicide and Self-harm appearing as the primary indexed condition, and to 2 interventions - of which Dialectical Behavior Therapy is the first listed.

NCT05842863 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05842863 about?

NCT05842863 is a clinical study titled "Combined Dialectical Behavior Therapy and Digital Cognitive Behavioral Therapy for Insomnia for Adolescents at High Risk for Suicide". The proposed research addresses the urgent need to reduce suicide rates among teens. This will be the first study that the investigators know of that will examine the feasibility and preliminary effectiveness of augmenting a suicide-focused treatment (Dialectical Behavior Therapy, \[DBT\]) with an e...

What is the current status of trial NCT05842863?

This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2024-08-14. Estimated completion is 2026-06-30.

What conditions does trial NCT05842863 study?

This clinical trial studies the following conditions: Suicide and Self-harm.

What interventions are being tested in trial NCT05842863?

The interventions under investigation include: Dialectical Behavior Therapy (BEHAVIORAL), Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL).

Who is sponsoring clinical trial NCT05842863?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05842863 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide and Self-harm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05842863's enrollment target sits among peer trials

44 8th of 11 higher than 4 of 11 other Suicide and Self-harm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide and Self-harm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323945 · 44 participants · NA

    Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury

  • NCT03093909 · 44 participants · Phase 1

    Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases

  • NCT03104491 · 44 participants · Phase 1

    Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

  • NCT03781765 · 44 participants · Phase 4

    Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05842863, the US trial registry maintained by the National Library of Medicine. NCT05842863 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.